1. Gianno, Francesca, Giovannoni, Isabella, Cafferata, Barbara, Giangaspero, Felice, Rossi, Sabrina. . Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification. In Pathologica, 114, 422-435. doi:10.32074/1591-951X-830. https://pubmed.ncbi.nlm.nih.gov/36534421/
2. Ragazzini, Roberta, Pérez-Palacios, Raquel, Baymaz, Irem H, Vermeulen, Michiel, Margueron, Raphaël. 2019. EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells. In Nature communications, 10, 3858. doi:10.1038/s41467-019-11800-x. https://pubmed.ncbi.nlm.nih.gov/31451685/
3. Cassim, Afraah, Dun, Matthew D, Gallego-Ortega, David, Valdes-Mora, Fatima. 2024. EZHIP's role in diffuse midline glioma: echoes of oncohistones? In Trends in cancer, 10, 1095-1105. doi:10.1016/j.trecan.2024.09.002. https://pubmed.ncbi.nlm.nih.gov/39343635/
4. Panwalkar, Pooja, Tamrazi, Benita, Dang, Derek, Judkins, Alexander R, Venneti, Sriram. 2021. Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas. In Science translational medicine, 13, eabc0497. doi:10.1126/scitranslmed.abc0497. https://pubmed.ncbi.nlm.nih.gov/34613815/
5. Jain, Siddhant U, Rashoff, Andrew Q, Krabbenhoft, Samuel D, Harrison, Melissa M, Lewis, Peter W. 2020. H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2. In Molecular cell, 80, 726-735.e7. doi:10.1016/j.molcel.2020.09.028. https://pubmed.ncbi.nlm.nih.gov/33049227/